These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15471560)

  • 1. Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers.
    Takada T; Yagi Y; Maekita T; Imura M; Nakagawa S; Tsao SW; Miyamoto K; Yoshino O; Yasugi T; Taketani Y; Ushijima T
    Cancer Sci; 2004 Sep; 95(9):741-4. PubMed ID: 15471560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SFRP1 promoter methylation and expression in human trabecular meshwork cells.
    Mao W; Rubin JS; Anoruo N; Wordinger RJ; Clark AF
    Exp Eye Res; 2012 Apr; 97(1):130-6. PubMed ID: 22248913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
    Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
    Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of 5-Aza-2-deoxycytidine on DNA methylation of anti-oncogenes in non-small cell lung cancer cells].
    Fang HL; Yu ZC; Zhu HB; Jin YT
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):658-63. PubMed ID: 23159077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic inactivation of the SFRP1 gene in esophageal squamous cell carcinoma.
    Meng Y; Wang QG; Wang JX; Zhu ST; Jiao Y; Li P; Zhang ST
    Dig Dis Sci; 2011 Nov; 56(11):3195-203. PubMed ID: 21567192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers.
    Yang ZQ; Liu G; Bollig-Fischer A; Haddad R; Tarca AL; Ethier SP
    Int J Cancer; 2009 Oct; 125(7):1613-21. PubMed ID: 19569235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.
    Kawamoto K; Hirata H; Kikuno N; Tanaka Y; Nakagawa M; Dahiya R
    Int J Cancer; 2008 Aug; 123(3):535-42. PubMed ID: 18404682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.
    Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ
    Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Wnt antagonist sFRP1 in colorectal tumorigenesis.
    Caldwell GM; Jones C; Gensberg K; Jan S; Hardy RG; Byrd P; Chughtai S; Wallis Y; Matthews GM; Morton DG
    Cancer Res; 2004 Feb; 64(3):883-8. PubMed ID: 14871816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epigenetic inactivation of the WNT antagonist SFRP1 in breast cancer].
    Dahl E; Veeck J; An H; Wiesmann F; Klopocki E; Sauter G; Kristiansen G; Hartmann A; Knüchel R
    Verh Dtsch Ges Pathol; 2005; 89():169-77. PubMed ID: 18035687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation-associated silencing of SFRP1 in renal cell carcinoma.
    Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O
    Oncol Rep; 2008 Nov; 20(5):1257-63. PubMed ID: 18949430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic silencing of the LDOC1 tumor suppressor gene in ovarian cancer cells.
    Buchholtz ML; Brüning A; Mylonas I; Jückstock J
    Arch Gynecol Obstet; 2014 Jul; 290(1):149-54. PubMed ID: 24554348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of Wnt antagonist genes: a useful prognostic marker for myelodysplastic syndrome.
    Wang H; Fan R; Wang XQ; Wu DP; Lin GW; Xu Y; Li WY
    Ann Hematol; 2013 Jan; 92(2):199-209. PubMed ID: 23093371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XAF1 is frequently methylated in human esophageal cancer.
    Chen XY; He QY; Guo MZ
    World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
    Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis.
    Veeck J; Niederacher D; An H; Klopocki E; Wiesmann F; Betz B; Galm O; Camara O; Dürst M; Kristiansen G; Huszka C; Knüchel R; Dahl E
    Oncogene; 2006 Jun; 25(24):3479-88. PubMed ID: 16449975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer.
    Fujikane T; Nishikawa N; Toyota M; Suzuki H; Nojima M; Maruyama R; Ashida M; Ohe-Toyota M; Kai M; Nishidate T; Sasaki Y; Ohmura T; Hirata K; Tokino T
    Breast Cancer Res Treat; 2010 Aug; 122(3):699-710. PubMed ID: 19859801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RUNX3 gene methylation in epithelial ovarian cancer tissues and ovarian cancer cell lines.
    Zhang S; Wei L; Zhang A; Zhang L; Yu H
    OMICS; 2009 Aug; 13(4):307-11. PubMed ID: 19645591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer.
    Stoehr R; Wissmann C; Suzuki H; Knuechel R; Krieg RC; Klopocki E; Dahl E; Wild P; Blaszyk H; Sauter G; Simon R; Schmitt R; Zaak D; Hofstaedter F; Rosenthal A; Baylin SB; Pilarsky C; Hartmann A
    Lab Invest; 2004 Apr; 84(4):465-78. PubMed ID: 14968126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.